Literature DB >> 19585249

Adenovirus vector production using low-multiplicity infection of 293 cells.

Kentaro Yamada1, Naoya Morishita, Tomohisa Katsuda, Shuji Kubo, Akinobu Gotoh, Hideki Yamaji.   

Abstract

The use of low-multiplicity infection of 293 cells in static culture with regular medium replacement was investigated for efficient large-scale production of adenovirus vectors for gene therapy applications. An adenovirus vector carrying the enhanced green fluorescent protein gene (Ad EGFP) was used to infect 293-F cells at a low multiplicity of infection (MOI) of 0.00001-0.1 transductional unit (TU) cell(-1). The cells, which have the ability to grow in suspension, were incubated in T-flasks and the serum-free culture medium was replaced with fresh medium via centrifugation every 2 days. Because only a small proportion of cells were initially infected at low MOIs (<1 TU cell(-1)), uninfected cells continued to grow until they were infected by progeny adenoviruses released from previously infected cells. When 293-F cells at a relatively low density of 1 x 10(5) cells cm(-3) were infected with Ad EGFP at a low MOI of 0.001 TU cell(-1), the vector yield was 2.7-fold higher than the maximum yield obtained with high-multiplicity infection (MOI = 10 TU cell(-1)) in batch culture. These results indicate that efficient adenovirus vector production using low MOIs is achieved by minimization of either nutrient depletion and/or accumulation of inhibitory metabolites in the culture medium.

Year:  2009        PMID: 19585249      PMCID: PMC2774567          DOI: 10.1007/s10616-009-9208-x

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

Review 1.  Gene therapy progress and prospects: adenoviral vectors.

Authors:  J A St George
Journal:  Gene Ther       Date:  2003-07       Impact factor: 5.250

2.  Production of adenovirus vector for gene therapy.

Authors:  Isabelle Nadeau; Amine Kamen
Journal:  Biotechnol Adv       Date:  2003-01       Impact factor: 14.227

3.  High-titer adenovirus vector production in 293S cell perfusion culture.

Authors:  Valérie Cortin; Jules Thibault; Danielle Jacob; Alain Garnier
Journal:  Biotechnol Prog       Date:  2004 May-Jun

4.  Influence of culture passages on growth kinetics and adenovirus vector production for gene therapy in monolayer and suspension cultures of HEK 293 cells.

Authors:  Min Tae Park; Myung Seop Lee; Sung Hyun Kim; Eui-Cheol Jo; Gyun Min Lee
Journal:  Appl Microbiol Biotechnol       Date:  2004-05-27       Impact factor: 4.813

5.  Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures.

Authors:  Olivier Henry; Edwige Dormond; Michel Perrier; Amine Kamen
Journal:  Biotechnol Bioeng       Date:  2004-06-30       Impact factor: 4.530

Review 6.  Adenoviral vectors for gene transfer and therapy.

Authors:  Christoph Volpers; Stefan Kochanek
Journal:  J Gene Med       Date:  2004-02       Impact factor: 4.565

7.  Low multiplicity infection of insect cells with a recombinant baculovirus: The cell yield concept.

Authors:  K T Wong; C H Peter; P F Greenfield; S Reid; L K Nielsen
Journal:  Biotechnol Bioeng       Date:  1996-03-20       Impact factor: 4.530

8.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  Study of adenovirus production in serum-free 293SF suspension culture by GFP-expression monitoring.

Authors:  J Côté; L Bourget; A Garnier; A Kamen
Journal:  Biotechnol Prog       Date:  1997 Nov-Dec

10.  Production of recombinant protein by baculovirus-infected insect cells in immobilized culture using porous biomass support particles.

Authors:  H Yamaji; S Tagai; K Sakai; E Izumoto; H Fukuda
Journal:  J Biosci Bioeng       Date:  2000       Impact factor: 2.894

View more
  2 in total

1.  Immobilization of 293 cells using porous support particles for adenovirus vector production.

Authors:  Naoya Morishita; Tomohisa Katsuda; Shuji Kubo; Akinobu Gotoh; Hideki Yamaji
Journal:  Cytotechnology       Date:  2010-02-06       Impact factor: 2.058

Review 2.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.